Prehospital reduction in BP does not improve stroke outcomes
May 20, 2024
The findings were seen in patients with suspected acute stroke with elevated systolic blood pressure.
ACC: Semaglutide beneficial in obesity-related heart failure, type 2 diabetes
Apr 09, 2024
Larger reductions were seen in heart failure-related symptoms and physical limitations for patients with HFpEF and type 2 diabetes.
Summer book release explores AI as a companion to offset loneliness
May 28, 2024
With an international epidemic of loneliness, artificial Intelligence, or AI, may offer technology-based social interaction and companionship. That’s according to robotics expert Tony Prescott, a professor...
Semaglutide reduces need for diuretics in heart failure
May 16, 2024
Medication also has a beneficial effect on the change in body weight across diuretic use categories.
New tool can predict individual’s dementia risk
Nov 18, 2022
The risk score model yielded almost 100% prediction accuracy of 13-year dementia risk.
Single dose of zilebesiran linked to reduction in systolic BP
Feb 20, 2024
A significant reduction was seen in systolic blood pressure with zilebesiran 150, 300 or 600 mg once in six months and 300 mg once every three months.
Watchdog group says US food recalls rose again last year
Apr 25, 2024
US recalls of foods for salmonella, foreign objects or undeclared allergens are rampant nowadays and the highest they’ve been since 2020, a watchdog group warns.
Gains in heart health only experienced by higher-income populations
Apr 19, 2024
The 10-year risk for cardiovascular disease remained stagnant at >8% for US adults with the lowest incomes in 1988 to 2018.
IV Ketamine not a ‘silver bullet’ for depression, but does help some
Feb 09, 2024
One-fourth with treatment-resistant depression show a response at six weeks.
Preexisting conditions seen in all patients with tachycardia after COVID-19 vaccine
Jan 10, 2024
Reduced heart rate variability was observed in patients with postvaccination postural orthostatic tachycardia syndrome.